
CRISPR knockout cell lines are engineered through targeted genome editing to eliminate gene function, supporting studies of cellular biology, disease mechanisms, and drug discovery.
ABHD16A (abhydrolase domain containing 16A, phospholipase) encodes a phospholipase associated with cellular immune functions. The protein belongs to a group of genes located within the major histocompatibility complex class III region and is thought to participate in aspects of immune regulation. ABHD16A is therefore relevant to studies investigating phospholipid metabolism and immune-related cellular processes.
BEAS-2B is an immortalized human bronchial epithelial cell line established from normal bronchial epithelium obtained from non-cancerous individuals. The cells were immortalized using a replication-defective SV40/adenovirus 12 hybrid (Ad12SV40) and cloned. BEAS-2B cells express epithelial markers including keratins and SV40 T antigen and can undergo squamous differentiation in response to serum exposure. The cell line is widely used as a model for studying normal airway epithelial biology, respiratory infection mechanisms, epithelial differentiation, environmental toxicity, and carcinogenesis.
Each knockout cell line is validated by STR authentication, sterility testing (bacteria/fungi), and mycoplasma screening. Genotype is confirmed by two rounds of PCR and Sanger sequencing. Only clones that pass all QC criteria are released, ensuring reliable identity and performance for downstream applications.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Targeted knockout region: EExon 5
Reference Transcript: NM_021160
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use






Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?